Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...
Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Phynart Studio / Getty Images A call option, ...
Photos: The annual Peeps chick drop rang in the new year early Wednesday night during PeepsFest in Bethlehem. An Allentown man is accused of shattering the doors to the federal courthouse, causing ...
Elvis Picardo is a regular contributor to Investopedia and has 25+ years of experience as a portfolio manager with diverse capital markets experience. Samantha (Sam) Silberstein, CFP®, CSLP®, EA, is ...
Some were public leaders; others were stalwarts in business, education, medicine, religion and other areas. The year’s list also included a world-renowned broadcast journalist, a Morning Call ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback